Ureteral Access Sheath Market By Type (Fr below 10, Fr 10-12, Fr 13-15) , By End User (Hospital, Specialty Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Ureteral Access Sheath Market
The ureteral access sheath market was valued at $1,293.6 million in 2023 and is estimated to reach $2,412.46 million by 2035, exhibiting a CAGR of 5.31% from 2024 to 2035
A ureteral access sheath is crucial equipment in urological procedures specifically used in interventions involving the urinary tract and kidneys. It is a flexible tube inserted into the ureter to form a path for other instruments, such as lasers and scopes, during minimally invasive surgeries such as ureteroscopy. The sheath enables repeated insertion and removal of instruments without causing any harm, which is beneficial in cases with multiple interventions or prolonged procedures. The easy access to the kidney and ureter offered by ureteral access sheath enables urologists to perform complex procedures with high precision and efficiency. According to research, ureteral access sheath lowers intraoperative intrarenal pressure and temperature by enhancing irrigation outflow during surgeries.
Increase in prevalence of kidney stone, developing healthcare infrastructure, and surge in adoption of minimally invasive procedures are the major drivers of the ureteral access sheath market. The cases of kidney stones have surged over the past few years due to unhealthy dietary habits and rise in obesity, dehydration, & metabolic disorders. As per a factsheet released by the Center of Disease Control and Prevention this year, around 6 million individuals are suffering from kidney stone in the U.S. Ureteral access sheaths play a crucial role in the treatment of such diseases, thereby witnessing a boost in demand.
However, the placement of ureteral access sheath is highly complex which requires significant training and practice. Incorrect placement usually leads to severe complications, hence constraining the market development. Moreover, there are several substitute approaches for the treatment of urinary diseases such as retrograde intrarenal surgery that do not use the sheath, hence limiting its adoption. Contrarily, according to a poster presented at the American Urological Association 2024 (AUA 2024) annual meeting, preoperative administration of tamsulosin, a medication which relaxes the prostate & bladder neck muscles, is able to successfully place the ureteral access sheath for treating kidney stones.
Segment Review
The global ureteral access sheath market is segmented into type, end user, and region. By type, the market is divided into Fr below 10, Fr 10-12, and Fr 13-15. On the basis of end user, it is classified into hospitals, specialty clinics, and ambulatory surgical centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the Fr below 10 segment dominated the market in 2023.
On the basis of end user, the specialty clinics segment acquired a high market share in 2023.
In North America, the market is robust, owing to mature healthcare system, and significant investments in R&D.
Competition Analysis
The major players operating in the ureteral access sheath market are Boston Scientific, Cook Medical, Coloplast Corp, Olympus Corporation, Karl Storz, Oscor Inc, Richard Wolf, Cogentix Medical, Becton, Dickinson and Company, and Envaste Ltd. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Key Market Segments
By Type
Fr below 10
Fr 10-12
Fr 13-15
By End User
Hospital
Specialty Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Boston Scientific Corporation
Cook Group
Coloplast Corp.
Olympus Corporation
Oscor Inc.
Karl Storz Endoscopy GmbH
Richard Wolf GmbH
COGENTIX MEDICAL
Becton, Dickinson and Company
Envaste Ltd
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: URETERAL ACCESS SHEATH MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Fr Below 10
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Fr 10-12
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Fr 13-15
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- CHAPTER 5: URETERAL ACCESS SHEATH MARKET, BY END USER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By End User
- 5.2. Hospital
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Specialty Clinics
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Ambulatory Surgical Centers
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: URETERAL ACCESS SHEATH MARKET, BY REGION
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Region
- 6.2. North America
- 6.2.1. Key Market Trends and Opportunities
- 6.2.2. Market Size and Forecast, By Type
- 6.2.3. Market Size and Forecast, By End User
- 6.2.4. Market Size and Forecast, By Country
- 6.2.5. U.S. Ureteral Access Sheath Market
- 6.2.5.1. Market Size and Forecast, By Type
- 6.2.5.2. Market Size and Forecast, By End User
- 6.2.6. Canada Ureteral Access Sheath Market
- 6.2.6.1. Market Size and Forecast, By Type
- 6.2.6.2. Market Size and Forecast, By End User
- 6.2.7. Mexico Ureteral Access Sheath Market
- 6.2.7.1. Market Size and Forecast, By Type
- 6.2.7.2. Market Size and Forecast, By End User
- 6.3. Europe
- 6.3.1. Key Market Trends and Opportunities
- 6.3.2. Market Size and Forecast, By Type
- 6.3.3. Market Size and Forecast, By End User
- 6.3.4. Market Size and Forecast, By Country
- 6.3.5. Germany Ureteral Access Sheath Market
- 6.3.5.1. Market Size and Forecast, By Type
- 6.3.5.2. Market Size and Forecast, By End User
- 6.3.6. France Ureteral Access Sheath Market
- 6.3.6.1. Market Size and Forecast, By Type
- 6.3.6.2. Market Size and Forecast, By End User
- 6.3.7. UK Ureteral Access Sheath Market
- 6.3.7.1. Market Size and Forecast, By Type
- 6.3.7.2. Market Size and Forecast, By End User
- 6.3.8. Italy Ureteral Access Sheath Market
- 6.3.8.1. Market Size and Forecast, By Type
- 6.3.8.2. Market Size and Forecast, By End User
- 6.3.9. Spain Ureteral Access Sheath Market
- 6.3.9.1. Market Size and Forecast, By Type
- 6.3.9.2. Market Size and Forecast, By End User
- 6.3.10. Rest Of Europe Ureteral Access Sheath Market
- 6.3.10.1. Market Size and Forecast, By Type
- 6.3.10.2. Market Size and Forecast, By End User
- 6.4. Asia-Pacific
- 6.4.1. Key Market Trends and Opportunities
- 6.4.2. Market Size and Forecast, By Type
- 6.4.3. Market Size and Forecast, By End User
- 6.4.4. Market Size and Forecast, By Country
- 6.4.5. Japan Ureteral Access Sheath Market
- 6.4.5.1. Market Size and Forecast, By Type
- 6.4.5.2. Market Size and Forecast, By End User
- 6.4.6. China Ureteral Access Sheath Market
- 6.4.6.1. Market Size and Forecast, By Type
- 6.4.6.2. Market Size and Forecast, By End User
- 6.4.7. Australia Ureteral Access Sheath Market
- 6.4.7.1. Market Size and Forecast, By Type
- 6.4.7.2. Market Size and Forecast, By End User
- 6.4.8. India Ureteral Access Sheath Market
- 6.4.8.1. Market Size and Forecast, By Type
- 6.4.8.2. Market Size and Forecast, By End User
- 6.4.9. South Korea Ureteral Access Sheath Market
- 6.4.9.1. Market Size and Forecast, By Type
- 6.4.9.2. Market Size and Forecast, By End User
- 6.4.10. Rest of Asia-Pacific Ureteral Access Sheath Market
- 6.4.10.1. Market Size and Forecast, By Type
- 6.4.10.2. Market Size and Forecast, By End User
- 6.5. LAMEA
- 6.5.1. Key Market Trends and Opportunities
- 6.5.2. Market Size and Forecast, By Type
- 6.5.3. Market Size and Forecast, By End User
- 6.5.4. Market Size and Forecast, By Country
- 6.5.5. Brazil Ureteral Access Sheath Market
- 6.5.5.1. Market Size and Forecast, By Type
- 6.5.5.2. Market Size and Forecast, By End User
- 6.5.6. Saudi Arabia Ureteral Access Sheath Market
- 6.5.6.1. Market Size and Forecast, By Type
- 6.5.6.2. Market Size and Forecast, By End User
- 6.5.7. South Africa Ureteral Access Sheath Market
- 6.5.7.1. Market Size and Forecast, By Type
- 6.5.7.2. Market Size and Forecast, By End User
- 6.5.8. Rest of LAMEA Ureteral Access Sheath Market
- 6.5.8.1. Market Size and Forecast, By Type
- 6.5.8.2. Market Size and Forecast, By End User
- CHAPTER 7: COMPETITIVE LANDSCAPE
- 7.1. Introduction
- 7.2. Top Winning Strategies
- 7.3. Product Mapping Of Top 10 Player
- 7.4. Competitive Dashboard
- 7.5. Competitive Heatmap
- 7.6. Top Player Positioning, 2023
- CHAPTER 8: COMPANY PROFILES
- 8.1. Boston Scientific Corporation
- 8.1.1. Company Overview
- 8.1.2. Key Executives
- 8.1.3. Company Snapshot
- 8.1.4. Operating Business Segments
- 8.1.5. Product Portfolio
- 8.1.6. Business Performance
- 8.1.7. Key Strategic Moves and Developments
- 8.2. Cook Group
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Operating Business Segments
- 8.2.5. Product Portfolio
- 8.2.6. Business Performance
- 8.2.7. Key Strategic Moves and Developments
- 8.3. Coloplast Corp.
- 8.3.1. Company Overview
- 8.3.2. Key Executives
- 8.3.3. Company Snapshot
- 8.3.4. Operating Business Segments
- 8.3.5. Product Portfolio
- 8.3.6. Business Performance
- 8.3.7. Key Strategic Moves and Developments
- 8.4. Olympus Corporation
- 8.4.1. Company Overview
- 8.4.2. Key Executives
- 8.4.3. Company Snapshot
- 8.4.4. Operating Business Segments
- 8.4.5. Product Portfolio
- 8.4.6. Business Performance
- 8.4.7. Key Strategic Moves and Developments
- 8.5. Oscor Inc.
- 8.5.1. Company Overview
- 8.5.2. Key Executives
- 8.5.3. Company Snapshot
- 8.5.4. Operating Business Segments
- 8.5.5. Product Portfolio
- 8.5.6. Business Performance
- 8.5.7. Key Strategic Moves and Developments
- 8.6. Karl Storz Endoscopy GmbH
- 8.6.1. Company Overview
- 8.6.2. Key Executives
- 8.6.3. Company Snapshot
- 8.6.4. Operating Business Segments
- 8.6.5. Product Portfolio
- 8.6.6. Business Performance
- 8.6.7. Key Strategic Moves and Developments
- 8.7. Richard Wolf GmbH
- 8.7.1. Company Overview
- 8.7.2. Key Executives
- 8.7.3. Company Snapshot
- 8.7.4. Operating Business Segments
- 8.7.5. Product Portfolio
- 8.7.6. Business Performance
- 8.7.7. Key Strategic Moves and Developments
- 8.8. COGENTIX MEDICAL
- 8.8.1. Company Overview
- 8.8.2. Key Executives
- 8.8.3. Company Snapshot
- 8.8.4. Operating Business Segments
- 8.8.5. Product Portfolio
- 8.8.6. Business Performance
- 8.8.7. Key Strategic Moves and Developments
- 8.9. Becton, Dickinson And Company
- 8.9.1. Company Overview
- 8.9.2. Key Executives
- 8.9.3. Company Snapshot
- 8.9.4. Operating Business Segments
- 8.9.5. Product Portfolio
- 8.9.6. Business Performance
- 8.9.7. Key Strategic Moves and Developments
- 8.10. Envaste Ltd
- 8.10.1. Company Overview
- 8.10.2. Key Executives
- 8.10.3. Company Snapshot
- 8.10.4. Operating Business Segments
- 8.10.5. Product Portfolio
- 8.10.6. Business Performance
- 8.10.7. Key Strategic Moves and Developments
- TABLE 1. GLOBAL URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 2. URETERAL ACCESS SHEATH MARKET FOR FR BELOW 10, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. URETERAL ACCESS SHEATH MARKET FOR FR 10-12, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. URETERAL ACCESS SHEATH MARKET FOR FR 13-15, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 5. GLOBAL URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 6. URETERAL ACCESS SHEATH MARKET FOR HOSPITAL, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. URETERAL ACCESS SHEATH MARKET FOR SPECIALTY CLINICS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. URETERAL ACCESS SHEATH MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 9. URETERAL ACCESS SHEATH MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. NORTH AMERICA URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 11. NORTH AMERICA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 12. NORTH AMERICA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 13. U.S. URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 14. U.S. URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 15. CANADA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 16. CANADA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 17. MEXICO URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 18. MEXICO URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 19. EUROPE URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 20. EUROPE URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 21. EUROPE URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 22. GERMANY URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 23. GERMANY URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 24. FRANCE URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 25. FRANCE URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. UK URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 27. UK URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 28. ITALY URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 29. ITALY URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 30. SPAIN URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 31. SPAIN URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 32. REST OF EUROPE URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 33. REST OF EUROPE URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 34. ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 35. ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 36. ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 37. JAPAN URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 38. JAPAN URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. CHINA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 40. CHINA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 41. AUSTRALIA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 42. AUSTRALIA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 43. INDIA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 44. INDIA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. SOUTH KOREA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 46. SOUTH KOREA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 48. REST OF ASIA-PACIFIC URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 49. LAMEA URETERAL ACCESS SHEATH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 50. LAMEA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 51. LAMEA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 52. BRAZIL URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 53. BRAZIL URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 54. SAUDI ARABIA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 55. SAUDI ARABIA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 56. SOUTH AFRICA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 57. SOUTH AFRICA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. REST OF LAMEA URETERAL ACCESS SHEATH MARKET, BY TYPE, 2024 - 2033 ($BILLION)
- TABLE 59. REST OF LAMEA URETERAL ACCESS SHEATH MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 60. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 61. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 62. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 63. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 64. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 65. COOK GROUP: KEY EXECUTIVES
- TABLE 66. COOK GROUP: COMPANY SNAPSHOT
- TABLE 67. COOK GROUP: OPERATING SEGMENTS
- TABLE 68. COOK GROUP: PRODUCT PORTFOLIO
- TABLE 69. COOK GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 70. COLOPLAST CORP.: KEY EXECUTIVES
- TABLE 71. COLOPLAST CORP.: COMPANY SNAPSHOT
- TABLE 72. COLOPLAST CORP.: OPERATING SEGMENTS
- TABLE 73. COLOPLAST CORP.: PRODUCT PORTFOLIO
- TABLE 74. COLOPLAST CORP.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 75. OLYMPUS CORPORATION: KEY EXECUTIVES
- TABLE 76. OLYMPUS CORPORATION: COMPANY SNAPSHOT
- TABLE 77. OLYMPUS CORPORATION: OPERATING SEGMENTS
- TABLE 78. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
- TABLE 79. OLYMPUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 80. OSCOR INC.: KEY EXECUTIVES
- TABLE 81. OSCOR INC.: COMPANY SNAPSHOT
- TABLE 82. OSCOR INC.: OPERATING SEGMENTS
- TABLE 83. OSCOR INC.: PRODUCT PORTFOLIO
- TABLE 84. OSCOR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 85. KARL STORZ ENDOSCOPY GMBH: KEY EXECUTIVES
- TABLE 86. KARL STORZ ENDOSCOPY GMBH: COMPANY SNAPSHOT
- TABLE 87. KARL STORZ ENDOSCOPY GMBH: OPERATING SEGMENTS
- TABLE 88. KARL STORZ ENDOSCOPY GMBH: PRODUCT PORTFOLIO
- TABLE 89. KARL STORZ ENDOSCOPY GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 90. RICHARD WOLF GMBH: KEY EXECUTIVES
- TABLE 91. RICHARD WOLF GMBH: COMPANY SNAPSHOT
- TABLE 92. RICHARD WOLF GMBH: OPERATING SEGMENTS
- TABLE 93. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
- TABLE 94. RICHARD WOLF GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 95. COGENTIX MEDICAL: KEY EXECUTIVES
- TABLE 96. COGENTIX MEDICAL: COMPANY SNAPSHOT
- TABLE 97. COGENTIX MEDICAL: OPERATING SEGMENTS
- TABLE 98. COGENTIX MEDICAL: PRODUCT PORTFOLIO
- TABLE 99. COGENTIX MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 100. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 101. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 102. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 103. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 104. BECTON, DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 105. ENVASTE LTD: KEY EXECUTIVES
- TABLE 106. ENVASTE LTD: COMPANY SNAPSHOT
- TABLE 107. ENVASTE LTD: OPERATING SEGMENTS
- TABLE 108. ENVASTE LTD: PRODUCT PORTFOLIO
- TABLE 109. ENVASTE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- FIGURE 1. GLOBAL URETERAL ACCESS SHEATH MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF URETERAL ACCESS SHEATH MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN URETERAL ACCESS SHEATH MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALURETERAL ACCESS SHEATH MARKET
- FIGURE 10. GLOBAL URETERAL ACCESS SHEATH MARKET SEGMENTATION, BY TYPE
- FIGURE 11. URETERAL ACCESS SHEATH MARKET FOR FR BELOW 10, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. URETERAL ACCESS SHEATH MARKET FOR FR 10-12, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. URETERAL ACCESS SHEATH MARKET FOR FR 13-15, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. GLOBAL URETERAL ACCESS SHEATH MARKET SEGMENTATION, BY END USER
- FIGURE 15. URETERAL ACCESS SHEATH MARKET FOR HOSPITAL, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. URETERAL ACCESS SHEATH MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. URETERAL ACCESS SHEATH MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 22. COMPETITIVE DASHBOARD
- FIGURE 23. COMPETITIVE HEATMAP: URETERAL ACCESS SHEATH MARKET
- FIGURE 24. TOP PLAYER POSITIONING, 2023
- FIGURE 25. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 26. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 27. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 28. COOK GROUP: NET SALES, 2021-2023 ($BILLION)
- FIGURE 29. COOK GROUP: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. COOK GROUP: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. COLOPLAST CORP.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. COLOPLAST CORP.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. COLOPLAST CORP.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. OLYMPUS CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. OLYMPUS CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. OSCOR INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. OSCOR INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. OSCOR INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. KARL STORZ ENDOSCOPY GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. KARL STORZ ENDOSCOPY GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. KARL STORZ ENDOSCOPY GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. RICHARD WOLF GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. RICHARD WOLF GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. RICHARD WOLF GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. COGENTIX MEDICAL: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. COGENTIX MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. COGENTIX MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. BECTON, DICKINSON AND COMPANY: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. BECTON, DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. ENVASTE LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. ENVASTE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. ENVASTE LTD: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook